T Cell | U/ml | |||
---|---|---|---|---|
Populationa | %mRNA+ Cellsb | Media | anti-CD3 | |
CD Patient #1 (Ileocolonic) | ||||
Total | N | 12 ± 4 | <5 | 39 ± 8 |
I | 39 ± 5 | 5 | 99 ± 10 | |
αβ+ T cells | N | 10 ± 2 | 10 ± 2 | 38 ± 10 |
I | 46 ± 10 | 9 ± 3 | 53 ± 14 | |
γδ+ T cells | ||||
(9% Vδ1 +) | N | 16 ± 4 | 7 ± 6 | 19 ± 2 |
(35% Vδ1+) | I | 39 ± 5 | 12 ± 4 | 109 ± 5 |
CD Patient #2 (Ileocolonic) | ||||
Total | N | 15 ± 3 | 8 ± 9 | 13 ± 2 |
I | 61 ± 6 | 7 ± 7 | 78 ± 9 | |
αβ+ T cells | N | 11 ± 5 | 6 ± 6 | 23 ± 5 |
I | 56 ± 8 | 13 ± 11 | 57 ± 8 | |
γδ+ T cells | ||||
(12% Vδ1+) | N | 17 ± 9 | 11 ± 8 | 18 ± 13 |
(53% Vδ1+) | I | 38 ± 7 | 24 ± 10 | 165 ± 11 |
CD Patient #3 (Colonic CD) | ||||
Total | N | 11 ± 6 | <5 | 59 ± 17 |
I | 35 ± 10 | 43 ± 19 | 78 ± 21 | |
αβ+ T cells | N | 29 ± 5 | 18 ± 9 | 39 ± 6 |
I | 39 ± 7 | 33 ± 11 | 54 ± 10 | |
γδ+ T cells | ||||
(15% Vδ1+) | N | 9 ± 3 | 12 ± 8 | 35 ± 12 |
(43% Vδ1+) | I | 66 ± 8 | 34 ± 15 | 177 ± 21 |